Saúde
HAPV3 — HAPVIDA PARTICIPAÇÕES E INVESTIMENTOS S.A.
CNPJ 05.197.443/0001-38 · listed classes: HAPV3 · CVM code 24392
The full history, year by year
The arrow opens the path from the figure down to the line in the regulator's file. A cell with ! carries a caveat; a dash is a withheld figure — hover for the reason. Nothing is hidden.
| indicator | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| ROE ⟶ | 137.5%! | 38.7% | 15.6% | 10.4% | 5.4% | 0.0% | -1.5% | -1.3% | -0.3% |
| ROIC ⟶ | — | 57.7% | 14.6% | 11.4% | 5.0%! | -0.3%! | 1.4%! | 0.9%! | 1.8%! |
| ROA ⟶ | 24.9%! | 21.0% | 9.8% | 6.0% | 2.9% | -1.6% | -1.0% | -0.9% | -0.2% |
| Gross margin ⟶ | 41.8% | 39.8% | 39.6% | 39.1% | 31.0% | 23.8% | 10.9% | 11.4% | 11.8% |
| EBIT margin ⟶ | 20.4% | 19.0% | 18.3% | 14.8% | 5.5% | -0.7% | 4.2% | 2.6% | 4.6% |
| Net margin ⟶ | 16.9% | 17.2% | 15.1% | 9.2% | 5.1% | -3.3% | -2.7% | -2.2% | -0.5% |
| Revenue growth (1y) ⟶ | — | 18.9% | 23.1% | 51.8% | 15.5% | 140.3% | 16.6% | 3.5% | 9.2% |
| Revenue growth (5y CAGR) ⟶ | — | — | — | — | — | 43.9% | 43.4% | 38.7% | 29.8% |
| Net debt/EBITDA ⟶ | -1.10x | -0.97x | 0.57x | -0.20x | 2.45x | 2.66x | 1.62x | 1.62x | 1.66x |
| Current ratio ⟶ | 0.83x | 1.29x | 1.24x | 1.65x | 1.04x | 1.06x | 1.38x | 2.11x | 1.90x |
The current year, quarter by quarter
As the company filed it in its interim report. The fourth quarter does not exist on its own in that filing — the closed year comes in the annual one, and we do not derive a Q4, so that a figure we computed never sits beside the figures the company reported. Filed on is the date the report became public, and the price is taken from it.
| quarter | revenue | profit | net margin | P/E TTM | P/B | filed on |
|---|---|---|---|---|---|---|
| 2024T1! | 1,321.4 | 59.2 | 4.5% | -73.9 | 0.68 | 2024-05-21 |
| 2024T2! | 437.1 | -380.7 | -87.1% | -60.8 | 0.68 | 2024-08-19 |
| 2024T3! | 7,733.4 | -81.5 | -1.1% | -46.5 | 0.51 | 2024-11-12 |
| 2025T1! | 1,469.2 | 185.9 | 12.7% | -33.6 | 0.36 | 2025-05-12 |
| 2025T2! | 862.8 | -331.5 | -38.4% | -36.1 | 0.36 | 2025-08-13 |
| 2025T3! | 7,918.1 | 87.1 | 1.1% | -40.7 | 0.33 | 2025-11-12 |
| 2026T1! | 1,391.8 | -100.7 | -7.2% | -12.7 | 0.11 | 2026-05-11 |
| 2026T2! | 1,218.9 | -75.8 | -6.2% | -26.2 | 0.09 | 2026-08-12 |
Full series, every quarter: GET /empresas/HAPV3/trimestres
Dividends per year
| year | per share | payments |
|---|---|---|
| 2021 | R$ 0.0625 | 5 |
| 2020 | R$ 0.3253 | 3 |
| 2019 | R$ 0.2770 | 2 |
| 2018 | R$ 0.1843 | 1 |
Piotroski F-Score 6/9 (2025) — what each criterion means.
Restated filings for this company
The regulator overwrites the old version; we keep both. Figures in R$ millions: first filing on the left, restatement on the right.
| fiscal year | account | first filing | restated |
|---|---|---|---|
| 2022 | DRE 3.02 | -18,093.7 | -23,812.9 |
| 2022 | DRE 3.03 | 5,655.1 | -1.1 |
| 2022 | DRE 3.11.01 | 0.0 | -1,719.5 |
| 2022 | BPA 1 | 73,213.7 | 71,858.4 |
| 2022 | BPP 2 | 73,213.7 | 71,858.4 |
| 2022 | DMPL 5.03 | 10,572.1 | 11,694.2 |
| 2022 | DMPL 5.05 | -819.4 | -1,761.7 |
| 2022 | DMPL 5.05.01 | -777.2 | -1,719.5 |
This company appears in
Other companies in Healthcare
15 more with a page, same CVM sector — a classification of the regulator's, not ours.
Take this into your code
GET /empresas/HAPV3/indicadores. WEGE3 is open for testing without a key; for the rest, create a free key (200 calls/day, no card).Price coverage: 2,081 sessions, 2018-04-25 → 2026-09-04 · methodology · how we verify
Numbers on this page are live. Data version 2026-09-01-supressao-declarada · page generated 2026-09-08 11:39 UTC. If this does not match /saude, you are reading a cached copy.